This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghorpade, A.
Right arrow Articles by Gendelman, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghorpade, A.
Right arrow Articles by Gendelman, H. E.

 Previous Article  |  Next Article 

Journal of Virology, July 2001, p. 6572-6583, Vol. 75, No. 14
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.14.6572-6583.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mononuclear Phagocyte Differentiation, Activation, and Viral Infection Regulate Matrix Metalloproteinase Expression: Implications for Human Immunodeficiency Virus Type 1-Associated Dementia

Anuja Ghorpade,1,* Raisa Persidskaia,1 Radhika Suryadevara,1 Myhanh Che,1 Xiao Juan Liu,2 Yuri Persidsky,1 and Howard E. Gendelman3

The Center for Neurovirology and Neurodegenerative Disorders, Department of Pathology and Microbiology,1 and Departments of Internal Medicine3 and Oral Biology,2 Nebraska Medical Center, Omaha, Nebraska 68198-5215

Received 1 November 2000/Accepted 19 April 2001

The pathogenesis of human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is mediated mainly by mononuclear phagocyte (MP) secretory products and their interactions with neural cells. Viral infection and MP immune activation may affect leukocyte entry into the brain. One factor that influences central nervous system (CNS) monocyte migration is matrix metalloproteinases (MMPs). In the CNS, MMPs are synthesized by resident glial cells and affect the integrity of the neuropil extracellular matrix (ECM). To ascertain how MMPs influence HAD pathogenesis, we studied their secretion following MP differentiation, viral infection, and cellular activation. HIV-1-infected and/or immune-activated monocyte-derived macrophages (MDM) and human fetal microglia were examined for production of MMP-1, -2, -3, and -9. MMP expression increased significantly with MP differentiation. Microglia secreted high levels of MMPs de novo that were further elevated following CD40 ligand-mediated cell activation. Surprisingly, HIV-1 infection of MDM led to the down-regulation of MMP-9. In encephalitic brain tissue, MMPs were expressed within perivascular and parenchymal MP, multinucleated giant cells, and microglial nodules. These data suggest that MMP production in MP is dependent on cell type, differentiation, activation, and/or viral infection. Regulation of MMP expression by these factors may contribute to neuropil ECM degradation and leukocyte migration during HAD.


* The Center for Neurovirology and Neurodegenerative Disorders, Departments of Pathology and Microbiology, 985215 Nebraska Medical Center, Omaha, NE 68198-5215. Phone: (402) 559-5275. Fax: (402) 559-8922. E-mail: aghorpad{at}unmc.edu.


Journal of Virology, July 2001, p. 6572-6583, Vol. 75, No. 14
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.14.6572-6583.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Muratori, C., Sistigu, A., Ruggiero, E., Falchi, M., Bacigalupo, I., Palladino, C., Toschi, E., Federico, M. (2007). Macrophages Transmit Human Immunodeficiency Virus Type 1 Products to CD4-Negative Cells: Involvement of Matrix Metalloproteinase 9. J. Virol. 81: 9078-9087 [Abstract] [Full Text]  
  • Hamill, C. E., Caudle, W. M., Richardson, J. R., Yuan, H., Pennell, K. D., Greene, J. G., Miller, G. W., Traynelis, S. F. (2007). Exacerbation of Dopaminergic Terminal Damage in a Mouse Model of Parkinson's Disease by the G-Protein-Coupled Receptor Protease-Activated Receptor 1. Mol. Pharmacol. 72: 653-664 [Abstract] [Full Text]  
  • Ancuta, P., Wang, J., Gabuzda, D. (2006). CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells.. J. Leukoc. Biol. 80: 1156-1164 [Abstract] [Full Text]  
  • Webster, N. L., Crowe, S. M. (2006). Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J. Leukoc. Biol. 80: 1052-1066 [Abstract] [Full Text]  
  • Persidsky, Y., Heilman, D., Haorah, J., Zelivyanskaya, M., Persidsky, R., Weber, G. A., Shimokawa, H., Kaibuchi, K., Ikezu, T. (2006). Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107: 4770-4780 [Abstract] [Full Text]  
  • Rock, R. B., Gekker, G., Hu, S., Sheng, W. S., Cheeran, M., Lokensgard, J. R., Peterson, P. K. (2004). Role of Microglia in Central Nervous System Infections. Clin. Microbiol. Rev. 17: 942-964 [Abstract] [Full Text]  
  • Gross, E., Amella, C. A., Pompucci, L., Franchin, G., Sherry, B., Schmidtmayerova, H. (2003). Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection. J. Leukoc. Biol. 74: 781-790 [Abstract] [Full Text]  
  • Zhou, J., Stohlman, S. A., Atkinson, R., Hinton, D. R., Marten, N. W. (2002). Matrix Metalloproteinase Expression Correlates with Virulence following Neurotropic Mouse Hepatitis Virus Infection. J. Virol. 76: 7374-7384 [Abstract] [Full Text]